proline has been researched along with Bile Duct Obstruction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, T; Nanmoku, K; Shimizu, T; Shinzato, T; Yagisawa, T | 1 |
| Liu, S; Su, M; Wei, M; Zhou, Z | 1 |
| Abdel Kawy, HS | 1 |
| Brown, RS; Burton, JR; Dodge, JL; Everson, GT; Levitsky, J; O'Leary, JG; Saxena, V; Stravitz, RT; Terrault, NA; Trotter, JF; Verna, EC | 1 |
4 other study(ies) available for proline and Bile Duct Obstruction
| Article | Year |
|---|---|
Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Bilirubin; Cholestasis; Cyclopropanes; Fatal Outcome; Hepacivirus; Hepatitis C; Humans; Kidney Transplantation; Lactams, Macrocyclic; Leucine; Liver Cirrhosis; Male; Middle Aged; Proline; Pyrrolidines; Quinoxalines; Sulfonamides; Transplant Recipients; Viral Load | 2019 |
Application of capillary electrophoresis coupling with electrochemiluminescence detection to estimate activity of leucine aminopeptidas.
Topics: Case-Control Studies; Cholestasis; Electrophoresis, Capillary; Enzyme Stability; Female; Hepatitis; Humans; Hydrogen-Ion Concentration; Leucine; Leucyl Aminopeptidase; Limit of Detection; Liver Neoplasms; Luminescent Measurements; Male; Proline; Reproducibility of Results; Signal-To-Noise Ratio | 2013 |
Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Topics: Actins; Animals; Cholestasis; Cilostazol; Common Bile Duct; Dose-Response Relationship, Drug; Hemoglobins; Ligation; Liver; Liver Cirrhosis; Male; Neovascularization, Pathologic; Portal Pressure; Proline; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
Topics: Antiviral Agents; Biomarkers; Cholestasis; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligopeptides; Proline; Recurrence; Retrospective Studies; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; United States; Viral Load | 2015 |